oleic acid has been researched along with omacor in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
An, WS; Bae, HR; Han, JY; Kim, KH; Kim, SE; Lee, SM; Park, Y; Rha, SH; Son, YK | 1 |
Aliaga, C; Calcagnotto, A; El-Bayoumy, K; Manni, A; Richie, JP; Schetter, SE; Trushin, N | 1 |
2 trial(s) available for oleic acid and omacor
Article | Year |
---|---|
Omega-3 fatty acid supplementation increases 1,25-dihydroxyvitamin D and fetuin-A levels in dialysis patients.
Topics: Adult; Aged; Aged, 80 and over; alpha-2-HS-Glycoprotein; Calcium; Cardiovascular Diseases; Diet; Dietary Supplements; Docosahexaenoic Acids; Drug Combinations; Eicosapentaenoic Acid; Energy Intake; Erythrocyte Membrane; Fatty Acids, Omega-3; Female; Fibroblast Growth Factor-23; Humans; Male; Middle Aged; Oleic Acid; Parathyroid Hormone; Peritoneal Dialysis; Phosphorus; Radioimmunoassay; Renal Dialysis; Vascular Calcification; Vitamin D | 2012 |
Stearoyl-CoA desaturase-1, a novel target of omega-3 fatty acids for reducing breast cancer risk in obese postmenopausal women.
Topics: Adult; Aged; Biomarkers; Body Mass Index; Breast Density; Breast Neoplasms; Docosahexaenoic Acids; Dose-Response Relationship, Drug; Drug Combinations; Eicosapentaenoic Acid; Estrogen Receptor Modulators; Fatty Acids; Fatty Acids, Monounsaturated; Fatty Acids, Omega-3; Female; Follow-Up Studies; Humans; Middle Aged; Obesity; Oleic Acid; Palmitic Acid; Postmenopause; Raloxifene Hydrochloride; Risk Factors; Stearoyl-CoA Desaturase | 2017 |